Little Green Pharma Receives Licence For Manufacturing Facility

By Company News | More Articles by Company News

 
Little Green Pharma (ASX: LGP) has received a manufacturing licence from the Therapeutic Goods Association (TGA), enabling it to manufacture medicinal cannabis in-house at its new Western Australia-based facility.

Receipt of the licence means LGP’s new facility in WA can operate in-house manufacturing of medicinal cannabis, avoiding competition for outsourced manufacturing services.